Form 8-K ARTELO BIOSCIENCES, INC. For: May 11
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/24/2026
- S&P 500, Nasdaq end down on tech stocks, investors weigh Iran moves
- Oil drops more than $2 despite new US sanctions on Iran
- UBS says bull market has further to run
- S&P 500 may pull back before midterms, but Citi says buy the dip
- Global yield relief evaporates as U.S. rates push back toward multi-decade peaks
- Wattmore and Eos Energy strike non-exclusive storage software deal
- Grand Canyon Education places CFO on leave amid stock trade probe
- S&P 500, Nasdaq end down on tech stocks, investors weigh Iran moves
- Funds sell $44bn in semiconductors on AI concerns
- RUM Group signs $13.7 billion GPU services deal, issues warrants
Artelo Biosciences terminates at-the-market offering agreement
May 15, 2026 4:03 PM EDTArtelo Biosciences Inc. (NASDAQ: ARTL) terminated its at-the-market offering agreement with R.F. Lafferty & Co., Inc., the company announced. The termination notice was provided on May 11, 2026, with the agreement ending on May 18, 2026.
The sales agreement, originally dated July 18, 2025, allowed Artelo to sell... More
